Influence of Donor Age on the Survival of Human Embryonic Dopaminergic Neural Grafts by Freeman, T. B. et al.
257
21.$7
Influence of Donor Age on the Survival ofHuman Embryonic
Dopaminergic Neural Grafts
*-t- T.B. Freeman G.M. Nauert*, P.R. Sanberg*, J.H. Kordower
//
Departments of *Neurosurgery and /Pharmacology, University ofSouth Florida, Tampa, FL 33606;
Tampa Women’s Health Center, Tampa, FL;
//Department ofNeurological Sciences,
Rush Presbyterian Medical Center, Chicago, IL 60606, USA
There is substantial variability worldwide in
the donor ages utilized in nigral transplantation
programs for the treatment of Parkinson’s dis-
ease. In multiple non-human species, it has been
repeatedly demonstrated that optimal graft sur-
vival occurs when embryonic nigral neurons are
harvested before the period of axonal extension,
most likely due to axotomy and cell death, of
older neurons/1; see 2,3/.
Neurons which form the human substantia
nigra develop within the ventricular zone pri-
marily between post-ovulatory (PO) day 33 and
63 /2,5/. The nigrostriatal bundle begins to
develop at approximately PO day 56/2/. From
this data it could be predicted that the optimal
period for suspension graft survival would occur
before PO day 56 /2,3/. Solid grafts in non-
human species have been found to have a
slightly longer donor age "window" for graft
harvesting than suspension grafts/see 3/.
We compared the ability of solid and suspen-
sion grafts of human embryonic dopaminergic
neurons at different embryonic ages to survive
grafting into 6-OHDA lesioned immuno-
suppressed rats. Donor age was determined
using the atlas of O’Rahilly and Mtiller/4, also
see 2/. Suspension grafts survived best from PO
day 37 to 56 with diminishing success through
PO day 65. These implants displayed numerous
healthy tyrosine-hydroxylase-immunoreactive
(TH-ir) neurons which sent extensive neuritic
processes into the host striatum. Conversely,
suspension grafts of human embryonic dopamin-
ergic neurons survived poorly when the donor
age was greater than PO 65 days.
In contrast to suspension grafts, solid im-
plants of human ventral mesencephalic tissue
displayed only modest survival of TH-ir neurons
derived from younger donors. These grafts also
displayed a limited host innervation. Good/
excellent survival of TH-ir neurons was observed
in solid grafts employing embryonic donors
between PO day 45 and 65. Only trace numbers
of TH-ir neurons Were present within grafts
derived from PO 72 tissue.
In conclusion, the upper age limit for survival
of human embryonic dopaminergic suspension
grafts correlates well with the period of devel-
opment of the human nigrostriatal pathway. Op-
timal donor ages for human nigral suspension
grafts range from PO day 37 to 56 days. The
donor age "window" for transplantation of solid
human embryonic dopaminergic grafts appears
to be extended by about nine days in comparison
with suspension grafts. In younger age ranges
(less than or equal to 41 days), intraparenchymal
suspension nigral grafts survive better than solid
grafts. The optimal donor age for intra-
parenchymal solid grafts ranges from PO day 45-
65. There appears to be a sharp fall-off in the
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Post Ovulatory Donor
Age (days) stage
Foot Graft Survival
Length (Best)
(mm) Suspension Solid
33 15 ***
37 16 **** **
41 17 ***** ***
45-56d 18-23 ***** *****
57 5.5 ***
65 7.5 0-** ****
72 8.5 0 trace
cells
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number of surviving dopaminergic neurons in
both solid and suspension grafts derived from
older donors. We suggest that clinical nigral
transplant programs for the treatment of Parkin-
son’s disease limit donor age to these dates.
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